ad04

Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04

February 04, 2026 09:35 ET  | Source: Adial Pharmaceuticals, Inc GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial…

4 hours ago